These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 8410880

  • 1. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
    Pelletier JP, Martel-Pelletier J.
    J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
    [Abstract] [Full Text] [Related]

  • 2. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
    Balazs EA.
    Surg Technol Int; 2004 Aug; 12():278-89. PubMed ID: 15455338
    [Abstract] [Full Text] [Related]

  • 3. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H, Burkhardt D, Sambrook P, March L.
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [Abstract] [Full Text] [Related]

  • 4. Viscosupplementation for osteoarthritis.
    Wright KE, Maurer SG, Di Cesare PE.
    Am J Orthop (Belle Mead NJ); 2000 Feb; 29(2):80-8; discussion 88-9. PubMed ID: 10695858
    [Abstract] [Full Text] [Related]

  • 5. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.
    Yustin D, Kryshtalskyj B, Galea A.
    J Orofac Pain; 1995 Feb; 9(4):375-9. PubMed ID: 8995909
    [Abstract] [Full Text] [Related]

  • 6. Viscosupplementation: a new concept in the treatment of osteoarthritis.
    Balazs EA, Denlinger JL.
    J Rheumatol Suppl; 1993 Aug; 39():3-9. PubMed ID: 8410881
    [Abstract] [Full Text] [Related]

  • 7. [Intra-articular injection of hyaluronan for the treatment of knee osteoarthritis].
    Fukuda K.
    Clin Calcium; 2004 Jul; 14(7):103-7. PubMed ID: 15577085
    [Abstract] [Full Text] [Related]

  • 8. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis.
    Adams ME.
    J Rheumatol Suppl; 1993 Aug; 39():16-8. PubMed ID: 8410879
    [Abstract] [Full Text] [Related]

  • 9. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW, Manolopoulos V, Mancer K, Staples J, Damyanovich A.
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [Abstract] [Full Text] [Related]

  • 10. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
    Anandacoomarasamy A, Bagga H, Ding C, Burkhardt D, Sambrook PN, March LM.
    J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
    [Abstract] [Full Text] [Related]

  • 11. Viscosupplementation for the arthritic ankle.
    Pleimann JH, Davis WH, Cohen BE, Anderson RB.
    Foot Ankle Clin; 2002 Sep; 7(3):489-94. PubMed ID: 12512404
    [Abstract] [Full Text] [Related]

  • 12. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T, Jerosch J, Beks P, Kemper F, Euller-Ziegler L, Bailleul F, Chevalier X.
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [Abstract] [Full Text] [Related]

  • 13. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
    Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E.
    Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
    [Abstract] [Full Text] [Related]

  • 14. The role of viscosupplementation in the ankle using hylan G-F 20.
    Carpenter B, Motley T.
    J Foot Ankle Surg; 2008 Sep; 47(5):377-84. PubMed ID: 18725116
    [Abstract] [Full Text] [Related]

  • 15. Viscosupplementation in patients with osteoarthritis of the knee.
    Cianflocco AJ.
    Postgrad Med; 2013 Jan; 125(1):97-105. PubMed ID: 23391675
    [Abstract] [Full Text] [Related]

  • 16. Current thinking on viscosupplementation in osteoarthritis.
    Jay GD.
    Med Health R I; 2004 Jul; 87(7):213-5. PubMed ID: 15354797
    [No Abstract] [Full Text] [Related]

  • 17. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
    Waddell D, Rein A, Panarites C, Coleman PM, Weiss C.
    Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
    [Abstract] [Full Text] [Related]

  • 18. Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
    Parenti D, Murray CW.
    Arthritis Rheum; 2001 Jun; 44(6):1470-1; author reply 1473-6. PubMed ID: 11407711
    [No Abstract] [Full Text] [Related]

  • 19. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.
    Wobig M, Dickhut A, Maier R, Vetter G.
    Clin Ther; 1998 Jun; 20(3):410-23. PubMed ID: 9663358
    [Abstract] [Full Text] [Related]

  • 20. [Hyaluronic acid viscosupplementation in the treatment of osteoarthritis].
    Xiang Y, Shi G, Yuan G.
    Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):58-60. PubMed ID: 7600879
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.